Personalized Clinical Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Personalized Clinical Trials in Brazil

Personalized Clinical Trials in Brazil – Cohortias the CRO of LATAM

In recent years, the field of medical research has witnessed a paradigm shift from a one-size-fits-all approach to a more personalized and targeted method. Personalized clinical trials, also known as precision medicine trials, are at the forefront of this transformative change.

In this blog, we will explore how personalized clinical trials are revolutionizing healthcare in Brazil, offering hope to patients and driving advancements in medical science.

Understanding Personalized Clinical Trials

Personalized clinical trials aim to customize medical treatments based on an individual’s unique characteristics, genetics, lifestyle factors, and disease patterns. By analyzing a patient’s genetic information and biomarkers, researchers can identify specific subgroups of patients who are more likely to respond positively to a particular treatment.

This approach not only improves treatment outcomes but also minimizes adverse effects, ultimately leading to more effective and tailored patient care.

The Landscape of Personalized Clinical Trials in Brazil

Brazil, as one of the largest and most diverse countries in the world, possesses a significant advantage in adopting personalized clinical trials. The nation’s vast and varied patient population provides an opportunity to conduct research on a wide range of medical conditions and genetic profiles.

Additionally, Brazil’s robust healthcare infrastructure and a growing pool of skilled researchers and scientists have positioned the country as a prime location for advancing precision medicine research.

Over the years, Brazil has taken significant steps to foster personalized clinical trials. The establishment of collaborative networks between academic institutions, healthcare providers, and pharmaceutical companies has facilitated the exchange of knowledge and resources, accelerating the progress of personalized medicine research in the country.

Challenges and Opportunities

While personalized clinical trials hold immense promise, they also present unique challenges. One of the key challenges is the need for sophisticated genetic testing and data analysis infrastructure. However, as technology continues to advance and become more accessible, the feasibility of conducting personalized clinical trials is expected to improve.

Another challenge lies in ensuring equitable representation of Brazil’s diverse population in clinical trials. Historically, medical research has often underrepresented minority groups, leading to potential disparities in treatment effectiveness. Addressing this issue is essential to ensure that the benefits of personalized medicine extend to all patients, regardless of their ethnic background or socioeconomic status.

Despite these challenges, the opportunities that personalized clinical trials offer are substantial. By participating in these trials, patients gain access to cutting-edge treatments tailored specifically to their needs, enhancing the likelihood of positive outcomes. Additionally, personalized medicine has the potential to identify novel therapeutic targets and treatment approaches, unlocking possibilities for managing and treating diseases that were previously considered challenging.

Personalized Clinical Trials in Brazil

Personalized Clinical Trials in Brazil

Personalized Clinical Trials in Brazil

Impacts on Healthcare in Brazil

The integration of personalized clinical trials into Brazil’s healthcare system has far-reaching implications. By targeting treatments to individuals who are most likely to benefit, healthcare resources can be allocated more efficiently, leading to cost savings and improved patient satisfaction.

Furthermore, the ability to identify treatment responders and non-responders early in the trial can significantly shorten the drug development process, accelerating the availability of life-saving therapies to patients.

Personalized clinical trials also hold promise for patients with rare diseases, who often struggle to find effective treatment options. By focusing on specific genetic profiles, personalized medicine trials can identify potential treatments tailored to the unique needs of these patients, offering renewed hope and improved quality of life.

Regulatory Framework and Ethical Considerations

As personalized clinical trials gain prominence in Brazil, it is essential to establish a robust regulatory framework to ensure patient safety, data privacy, and ethical conduct. Regulatory bodies such as the Brazilian Health Regulatory Agency (ANVISA) play a pivotal role in evaluating and approving clinical trials, safeguarding the rights of participants and upholding the integrity of research.

Transparency in communication and obtaining informed consent from patients are fundamental to ensure that participants fully understand the potential risks and benefits of participating in personalized clinical trials.


Personalized clinical trials represent a significant advancement in medical research, offering hope and improved patient care in Brazil. As the country continues to embrace precision medicine, continued investments in research, technology, and regulatory oversight will drive the field forward. The goal is to provide patients with personalized treatments that optimize outcomes, enhance quality of life, and offer solutions where traditional approaches have fallen short.

By harnessing the power of precision medicine, Brazil is shaping a new era of patient-centered care that has the potential to transform lives and redefine the future of healthcare. Through collaborative efforts and a commitment to innovation, Brazil is poised to become a leader in the era of personalized medicine, benefitting patients throughout the nation and contributing to global advancements in medical science.

Personalized Clinical Trials in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Personalized Clinical Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Personalized Clinical Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Personalized Clinical Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Personalized Clinical Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Personalized Clinical Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Personalized Clinical Trials in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Personalized Clinical Trials in Brazil

The Cohortias Team

Personalized Clinical Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Personalized Clinical Trials in Brazil

Network & Partnerships